Description
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and PDGFRβ (IC50=80/2 nM). It exhibits antitumor activity and is used for treating kidney cancer and gastrointestinal tumors.
Molecular Formula
C22H27FN4O2
Smiles
C(=C\1/C=2C(NC1=O)=CC=C(F)C2)\C3=C(C)C(C(NCCN(CC)CC)=O)=C(C)N3
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 25 mg/mL (62.74 mM)10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1.25 mg/mL (3.14 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.H2O: < 1 mg/mL (insoluble or slightly soluble)Ethanol: < 1 mg/mL (insoluble or slightly soluble)